A previous study showed that metformin treatment reversed chemoresistance in breast cancer, and significantly inhibited multidrug resistance 1 (MDR1) gene transcription, which eventually significantly reduced the amount of the intracellular P-glycoprotein. The gene discussed is ABCB1; the disease is breast cancer.